http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2641464-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2731e707dc726508a6e2b55d44d3617c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 1989-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_279459816284ab4149172266c18bbad0 |
| publicationDate | 1990-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2641464-A1 |
| titleOfInvention | NOVEL PHARMACEUTICAL COMPOSITIONS EXPRESSING INHIBITORY PROPERTIES IN RESPECT OF A2 PHOSPHOLIPASE |
| abstract | The present invention relates to novel pharmaceutical compositions exhibiting inhibitory properties with respect to phospholipase A2. It contains as active principle at least one derivative of (4-aroyl pyrrolyl-2) carboxylic acid of general formula: (CF DRAWING IN BOPI) The invention also relates to the use of the compounds of general formula 1 with a view to the production of a drug ensuring the in vivo inhibition of phospholipases A2. |
| priorityDate | 1989-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.